Mäkitie Antti A, Törnwall Jyrki, Mäkitie Outi
Department of Otolaryngology--Head and Neck Surgery, Helsinki University Hospital, P.O. Box 220, 00029 Helsinki, Finland.
Clin Rheumatol. 2008 Jun;27(6):809-12. doi: 10.1007/s10067-008-0842-z. Epub 2008 Feb 5.
Fibrous dysplasia (FD) is a benign skeletal disorder which may affect one or multiple bones. Lesions often involve long bones, ribs, and craniofacial bones and cause pain, fractures, and disfigurement. We describe an adolescent girl with mandibular FD who was successfully treated with bisphosphonates. She presented with a tumor-like lesion of the mandible. During the 2-year follow-up, the lesion expanded and caused significant disfigurement and pain necessitating psychiatric support. Treatment with bisphosphonate administered intravenously resulted in rapid pain relief, normalization of bone turnover, and cosmetic improvement. Management of FD has previously consisted of either conservative follow-up or surgery depending on disease activity and localization. Based on published reports and our experience, bisphosphonates should be considered in the treatment of symptomatic cases. This line of treatment may be suitable especially for craniofacial FD in which surgical treatment is particularly challenging.
骨纤维异常增殖症(FD)是一种良性骨骼疾病,可累及一块或多块骨骼。病变常累及长骨、肋骨和颅面骨,导致疼痛、骨折和畸形。我们描述了一名患有下颌骨FD的青春期女孩,她通过双膦酸盐治疗成功治愈。她表现为下颌骨的肿瘤样病变。在2年的随访期间,病变扩大,导致明显的畸形和疼痛,需要精神支持。静脉注射双膦酸盐治疗导致疼痛迅速缓解、骨转换正常化和外观改善。FD的治疗以前根据疾病活动和部位,要么采取保守随访,要么进行手术。根据已发表的报告和我们的经验,对于有症状的病例,应考虑使用双膦酸盐治疗。这种治疗方法可能特别适用于颅面骨FD,因为手术治疗极具挑战性。